Masakazu Nitta Selected Research

Masakazu Nitta Research Topics

Disease

13	Leukemia 07/2014 - 01/2002
8	Neoplasms (Cancer) 12/2018 - 06/2003
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2014 - 06/2003
4	Multiple Myeloma 11/2015 - 04/2002
3	Acute Promyelocytic Leukemia 02/2013 - 01/2002
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 04/2006
2	Hypoxia (Hypoxemia) 02/2014 - 12/2002
2	Thrombocytosis (Thrombocythemia) 07/2010 - 06/2004
2	Genetic Translocation (Chromosomal Translocation) 12/2009 - 04/2003
2	Essential Thrombocythemia 10/2009 - 06/2004
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2005 - 06/2002
2	Hepatitis 01/2004 - 03/2002
1	Hemorrhage 01/2020
1	Sepsis (Septicemia) 01/2020
1	Critical Illness (Critically Ill) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2012
1	Hypesthesia (Numbness) 07/2010
1	Thrombosis (Thrombus) 07/2010
1	Hyperthermia 05/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2005
1	Colitis 12/2005
1	Philadelphia Chromosome 10/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2005
1	Massive Hepatic Necrosis 05/2004
1	Fever (Fevers) 01/2004
1	Hypersensitivity (Allergy) 01/2004
1	Hypotension (Low Blood Pressure) 01/2004
1	Persistent Infection 01/2004
1	Epstein-Barr Virus Infections 01/2004
1	Acute Kidney Injury (Acute Renal Failure) 10/2003
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2003
1	Hematologic Neoplasms (Hematological Malignancy) 06/2003
1	Plasma Cell Neoplasms 04/2003
1	Monoclonal Gammopathy of Undetermined Significance 04/2003
1	Smoldering Multiple Myeloma 04/2003

Drug/Important Bio-Agent (IBA)

3	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 04/2002
3	Deoxyglucose (2 Deoxy D glucose)IBA 09/2013 - 11/2010
3	Pharmaceutical PreparationsIBA 07/2010 - 01/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009 - 01/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2014 - 12/2002
2	Oxygen (Dioxygen)IBA 02/2014 - 12/2002
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2009 - 04/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2009 - 11/2002
2	Messenger RNA (mRNA)IBA 04/2006 - 01/2002
2	Melphalan (Alkeran)FDA LinkGeneric 11/2002 - 04/2002
1	Synthetic CathinoneIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Cyclin DIBA 12/2018
1	Bortezomib (Velcade)FDA Link 11/2015
1	Amylases FDA Link 11/2015
1	Oxaloacetic Acid (Oxalacetic Acid)IBA 07/2014
1	Glutamine (L-Glutamine)FDA Link 07/2014
1	Tricarboxylic AcidsIBA 07/2014
1	Peptide Hydrolases (Proteases)FDA Link 02/2014
1	CarbohydratesIBA 09/2013
1	EnzymesIBA 09/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2013
1	Arsenic Trioxide (Trisenox)FDA Link 02/2013
1	HLA-DR Antigens (HLA-DR)IBA 01/2012
1	OligomycinsIBA 11/2010
1	Ticlopidine (Ticlid)FDA LinkGeneric 07/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2009
1	Monoclonal AntibodiesIBA 12/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 10/2009
1	Thrombopoietin ReceptorsIBA 10/2009
1	Amino Acids FDA Link 10/2009
1	antineoplaston A10 (A 10)IBA 05/2009
1	Angiogenesis InhibitorsIBA 12/2006
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 04/2006
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2005
1	Placenta Growth FactorIBA 10/2005
1	Serine (L-Serine)FDA Link 06/2004
1	AsparagineIBA 06/2004
1	Thrombopoietin (c-mpl Ligand)IBA 06/2004
1	Immunoglobulin M (IgM)IBA 01/2004
1	Epstein-Barr viral capsid antigenIBA 01/2004
1	AngiopoietinsIBA 01/2004
1	Alkylating AgentsIBA 06/2003
1	Biological ProductsIBA 06/2003
1	Topoisomerase II InhibitorsIBA 06/2003
1	Cyclin D1IBA 04/2003
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2003
1	Glucose (Dextrose)FDA LinkGeneric 12/2002
1	Protein Kinase InhibitorsIBA 12/2002
1	Phosphotransferases (Kinase)IBA 12/2002

Therapy/Procedure

8	Therapeutics 02/2014 - 06/2003
6	Drug Therapy (Chemotherapy) 02/2013 - 01/2002
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 10/2003
2	Artificial Liver (Bioartificial Liver) 01/2005 - 06/2002
1	Critical Care (Surgical Intensive Care) 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Thrombectomy 07/2010
1	Radiotherapy 05/2009
1	Hemodiafiltration 01/2005
1	Plasma Exchange 01/2005
1	Blood Component Removal (Apheresis) 05/2004
1	Consolidation Chemotherapy 01/2004